| Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh F Qadri, TF Wierzba, M Ali, F Chowdhury, AI Khan, A Saha, IA Khan, ... New England Journal of Medicine 374 (18), 1723-1732, 2016 | 169 | 2016 |
| Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial F Qadri, M Ali, F Chowdhury, AI Khan, A Saha, IA Khan, YA Begum, ... The Lancet 386 (10001), 1362-1371, 2015 | 146 | 2015 |
| Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut F Qadri, TR Bhuiyan, KK Dutta, R Raqib, MS Alam, NH Alam, ... Gut 53 (1), 62-69, 2004 | 113 | 2004 |
| Immune responses and protection in children in developing countries induced by oral vaccines F Qadri, TR Bhuiyan, DA Sack, AM Svennerholm Vaccine 31 (3), 452-460, 2013 | 109 | 2013 |
| Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea T Ahmed, TR Bhuiyan, K Zaman, D Sinclair, F Qadri Cochrane Database of Systematic Reviews, 2013 | 109 | 2013 |
| Circulating Mucosal Associated Invariant T Cells Are Activated in Vibrio cholerae O1 Infection and Associated with Lipopolysaccharide Antibody Responses DT Leung, TR Bhuiyan, NS Nishat, MR Hoq, A Aktar, MA Rahman, ... PLoS neglected tropical diseases 8 (8), e3076, 2014 | 97 | 2014 |
| Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo … F Qadri, M Akhtar, TR Bhuiyan, MI Chowdhury, T Ahmed, TA Rafique, ... The Lancet Infectious Diseases 20 (2), 208-219, 2020 | 93 | 2020 |
| Broad up-regulation of innate defense factors during acute cholera CF Flach, F Qadri, TR Bhuiyan, NH Alam, E Jennische, I Lönnroth, ... Infection and immunity 75 (5), 2343-2350, 2007 | 91 | 2007 |
| Histo–blood group antigen phenotype determines susceptibility to genotype-specific rotavirus infections and impacts measures of rotavirus vaccine efficacy B Lee, DM Dickson, AC deCamp, E Ross Colgate, SA Diehl, MI Uddin, ... The Journal of infectious diseases 217 (9), 1399-1407, 2018 | 87 | 2018 |
| Immunologic Responses to Vibrio cholerae in Patients Co-Infected with Intestinal Parasites in Bangladesh JB Harris, MJ Podolsky, TR Bhuiyan, F Chowdhury, AI Khan, ... PLoS neglected tropical diseases 3 (3), e403, 2009 | 87 | 2009 |
| Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh T Shirin, TR Bhuiyan, RC Charles, S Amin, I Bhuiyan, Z Kawser, A Rahat, ... International Journal of Infectious Diseases 101, 220-225, 2020 | 86 | 2020 |
| Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial F Qadri, M Ali, J Lynch, F Chowdhury, AI Khan, TF Wierzba, JL Excler, ... The Lancet Infectious Diseases 18 (6), 666-674, 2018 | 79 | 2018 |
| Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris HC De Oliveira, MC Monteiro, SA Rossi, J Pemán, A Ruiz-Gaitán, ... Frontiers in cellular and infection microbiology 9, 83, 2019 | 77* | 2019 |
| Single-cell analysis of the plasmablast response to Vibrio cholerae demonstrates expansion of cross-reactive memory B cells RC Kauffman, TR Bhuiyan, R Nakajima, LM Mayo-Smith, R Rashu, ... MBio 7 (6), 10.1128/mbio. 02021-16, 2016 | 73 | 2016 |
| Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country A Lundgren, TR Bhuiyan, D Novak, J Kaim, A Reske, YJ Lu, F Qadri, ... Vaccine 30 (26), 3897-3907, 2012 | 72 | 2012 |
| Infection by Helicobacter pylori in Bangladeshi children from birth to two years: relation to blood group, nutritional status, and seasonality TR Bhuiyan, F Qadri, A Saha, AM Svennerholm The Pediatric infectious disease journal 28 (2), 79-85, 2009 | 70 | 2009 |
| Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera CN Ellis, RC LaRocque, T Uddin, B Krastins, LM Mayo-Smith, D Sarracino, ... Infection and immunity 83 (3), 1089-1103, 2015 | 67 | 2015 |
| A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain … MA Sayeed, MK Bufano, P Xu, G Eckhoff, RC Charles, MM Alam, ... PLoS neglected tropical diseases 9 (7), e0003881, 2015 | 61 | 2015 |
| LPLUNC1 modulates innate immune responses to Vibrio cholerae OS Shin, T Uddin, R Citorik, JP Wang, P Della Pelle, RL Kradin, ... Journal of Infectious Diseases 204 (9), 1349-1357, 2011 | 61 | 2011 |
| Estimating cholera incidence with cross-sectional serology AS Azman, J Lessler, FJ Luquero, TR Bhuiyan, AI Khan, F Chowdhury, ... Science translational medicine 11 (480), eaau6242, 2019 | 58 | 2019 |
